Rash News and Research

RSS

Topical treatment for psoriasis, eliminates need for injections

Apollo Life Sciences, a Sydney-based biotechnology company, has announced that its topical psoriasis treatment has outperformed current market-leading drugs in preclinical studies.

17 Oct 2006

FDA approves Noxafil (posaconazole) to prevent invasive fungal infections

The U.S. Food and Drug Administration has approved Noxafil (posaconazole) to prevent fungal infections caused by certain molds and yeast-like fungus called Aspergillus and Candida.

19 Sep 2006

Chemical concerns over skincare

Did you know that the average woman uses 12 toiletries every day and applies more than 175 chemical compounds to her body in the process?

5 Sep 2006

Lyme disease vaccine could be on the cards

Lyme disease is the most common tick-borne disease in the Northern Hemisphere, and the most common tick-borne illness in the United States and Europe.

24 Aug 2006

British farmer dies from rabbit flu

An apparently healthy young farmer in Britain has died from rabbit flu.

21 Aug 2006

Simple policies could control a smallpox epidemic

A series of simple public health policies would be able to effectively contain the spread of smallpox if it were released into a population, according to research published in PNAS.

27 Jul 2006

Children with eczema have the same impaired quality of life as those with kidney disease

Children with serious skin conditions feel their quality of life is impaired to the same extent as those with chronic illnesses such as epilepsy, renal disease and diabetes, according to research published in the July issue of British Journal of Dermatology.

18 Jul 2006

77 die from rare tropical disease on island paradise

Travellers to an exotic island in the Indian Ocean have been issued with warnings against a rare tropical disease.

17 Jul 2006

FDA approves Atripla for the treatment of HIV-1 infection in adults

Bristol-Myers Squibb Company and Gilead Sciences have announced the U.S. Food and Drug Administration (FDA) has granted approval of Atripla (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) for the treatment of HIV-1 infection in adults.

13 Jul 2006

FDA approves Atripla three-drug combination tablet for treatment of HIV-1

FDA approves Atripla Tablets, a fixed-dose combination of three widely-used antiretroviral drugs.

12 Jul 2006

3-drug pill will help fight HIV/AIDS

The Food and Drug Administration (FDA) in the U.S. has granted approval for a three-ingredient fixed dose tablet for use as an antiretroviral treatment for human immunodeficiency virus (HIV-1) infection in adults.

3 Jul 2006

FDA grants accelerated approval for Sprycel (dasatinib)

FDA grants accelerated approval for Sprycel (dasatinib), a new oral treatment for patients with chronic myeloid leukemia (CML),

29 Jun 2006

FDA gives tentative approval for generic pediatric AIDS drug

The Food and Drug Administration (FDA) today announced the tentative approval of the generic version of Abacavir Sulfate Oral Solution.

27 Jun 2006

First drug treatment for late-stage cervical cancer approved

FDA has approved a combination of Hycamtin (topotecan hydrochloride) and cisplatin for use as the first drug treatment for women with late-stage cancer of the cervix.

18 Jun 2006

New football boots and toxic shock syndrome

As the World Cup kicks off, doctors in this week's British Medical Journal report an unusual condition that can develop in budding young footballers.

8 Jun 2006

Study shows skin rash in patients treated for liver cancer determines survival

In a study of a new chemotherapy drug for liver cancer, researchers found that the development of a skin rash correlated directly with the patient's response to treatment.

6 Jun 2006

Hydrophobic statins not associated with increased breast cancer risk

A report published in the Journal of the National Cancer Institute found that women who took statins--the widely used cholesterol lowering drugs--do not face an increased breast cancer risk as had been suggested by some previous studies.

6 Jun 2006

New vaccine reduces the risk of shingles

A new vaccine which reduces the risk of shingles (herpes zoster) for use in people 60 years of age and older has won approval from the U.S. Food and Drug Administration.

29 May 2006

Heroin plus pain killer proves to be a lethal combo

According to health officials and the Chicago police a deadly combination of heroin and a prescription pain killer has resulted in one death and 21 others becoming ill.

15 May 2006

Treatment with intravenous and oral antiviral medications may help relieve nerve pain related to shingles

A small trial suggests that treatment with intravenous and oral antiviral medications may reduce the nerve pain that occurs following shingles, according to a study posted online today that will appear in the July 2006 print issue of Archives of Neurology.

9 May 2006